Panacea Biotec Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 60.68 | 96.76 | 98.28 |
| Operating Expense | 67.37 | 89.61 | 88.59 |
| Net Profit | -13.78 | -1.37 | 0.43 |
| Net Profit Margin | -22.71 | -1.42 | 0.44 |
| Earning Per Share | -2.25 | -0.22 | 0.07 |
| EBIDTA | -5.49 | 7.13 | 9.69 |
| Effective Tax Rate | TBA | TBA | 6.60 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 60.68 |
| Operating Expense | 67.37 |
| Net Profit | -13.78 |
| Net Profit Margin | -22.71 |
| Earning Per Share | -2.25 |
| EBIDTA | -5.49 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 257.07 | 235.50 | 343.56 |
| Operating Expenses Annual | 319.69 | 308.17 | 343.07 |
| Operating Profit Annual | -28.19 | -60.10 | 21.21 |
| Interest Annual | 10.06 | 7.04 | 7.52 |
| Depreciation | 24.48 | 25.95 | 26.01 |
| Net Profit Annual | -87.54 | -93.58 | -14.41 |
| Tax Annual | 24.79 | TBA | 1.56 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 257.07 |
| Operating Expenses Annual | 319.69 |
| Operating Profit Annual | -28.19 |
| Interest Annual | 10.06 |
| Depreciation | 24.48 |
| Net Profit Annual | -87.54 |
| Tax Annual | 24.79 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 5.33 | 8.66 | 14.92 |
| Cash Flow from Operations | -10.74 | -52.69 | 38.27 |
| Cash Flow from Investing | 2.41 | 39.54 | -37.32 |
| Cash Flow from Financing | 9.01 | 9.83 | -7.20 |
| Cash Flow at the End | 6.01 | 5.33 | 8.66 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 5.33 |
| Cash Flow from Operations | -10.74 |
| Cash Flow from Investing | 2.41 |
| Cash Flow from Financing | 9.01 |
| Cash Flow at the End | 6.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | -10.97 | -25.52 | 5.22 |
| PBIT Margin (%) | -20.50 | -36.75 | -2.51 |
| PBT Margin (%) | -18.46 | -31.53 | -2.18 |
| Net PROFIT Margin (%) | -34.05 | -39.74 | -4.20 |
| Return On Networth / Equity (%) | TBA | TBA | -2.53 |
| Return On Networth /Employed (%) | TBA | TBA | -1.10 |
| Return On Assets (%) | -18.05 | -16.69 | -1.85 |
| Total Debt / Equity (X) | 0.25 | 0.16 | 0.09 |
| Asset Turnover Ratio (%) | 0.53 | 0.42 | 0.44 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | -10.97 |
| PBIT Margin (%) | -20.50 |
| PBT Margin (%) | -18.46 |
| Net PROFIT Margin (%) | -34.05 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -18.05 |
| Total Debt / Equity (X) | 0.25 |
| Asset Turnover Ratio (%) | 0.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 396.74 | 416.15 | 398.48 |
| Total Current Assets Annual | 199.13 | 248.83 | 292.55 |
| Non Current Assets Annual | 518.77 | 473.01 | 497.74 |
| Total Shareholders Funds Annual | 325.65 | 415.09 | 508.17 |
| Total Assets Annual | 723.90 | 761.83 | 790.28 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 396.74 |
| Total Current Assets Annual | 199.13 |
| Non Current Assets Annual | 518.77 |
| Total Shareholders Funds Annual | 325.65 |
| Total Assets Annual | 723.90 |
EPS (INR)
Expected
0.00
Reported
-2.59
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.00%
